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CASE REPORT
Conversion of cardiac bypass into an extracorporeal membrane oxygenation
circuit: a case from Pakistan
Riffat Rasheed,1 Ijaz Hidayat,2 Muneer Amanullah,3 Babar Sultan Hasan4

Abstract
A 35 days old neonate with d-loop transposition of great
arteries, underwent an arterial switch operation
following which he developed hypotension attributed
to left ventricular failure. During cardiopulmonary
resuscitation decision was made to place him on cardiac
bypass again. Due to limited resources and
unavailability of a specialized extracorporeal membrane
oxygenator machine, the CPB was modified and
converted an ECMO. The neonate was successfully
decannulated after 72 hours and discharged home after
3 weeks of the operation without any sequel. ECMO is a
viable option in developing countries and may help in
improving the outcome especially in neonatal
congenital heart disease.
Keywords: ECMO, Paediatrics, Developing country.

Introduction
The use of Extracorporeal membrane oxygenation
(ECMO) in reversible cardiac or respiratory failure and
protracted cardiopulmonary resuscitation (CPR)
refractory to conventional intensive care measures is well
documented.1-4 ECMO also serve as a bridge for heart
transplantation in developed countries.5,6 However, its
usage in developing countries is still extremely limited
due to high cost, equipment unavailability and lack of
trained staff.7 We report here a case of ECMO use, at a
tertiary care hospital in Pakistan.

Case Report
The case of a neonate born at full term by normal vaginal
delivery and to consanguineous parents with no family
history of congenital heart disease is presented.
At 10th day of life our patient was diagnosed with d-loop
transposition of great arteries (d-loop TGA) and
underwent emergent balloon atrial septostomy at The
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Aga Khan University Hospital, Karachi, Pakistan. He was
electively admitted at 33 days of age for an arterial switch
operation (ASO). Pre-operative echocardiogram showed
appropriate left ventricular (LV) mass and normal
biventricular function. ASO was performed in September
2012 with no intra-operative issue. Total bypass time was
165 minutes with an aortic cross clamp time of 75
minutes. After coming off the cardiac bypass (CPB), he
developed hypotension which was responsive to fluid
and inotropes. An epicardial echocardiogram
demonstrated a LV ejection fraction (LVEF) of 40%.. He
was shifted to cardiac intensive care unit (CICU) with an
open chest (a usual practice in our institute) on a high
inotropic score (IS) of 20 comprising of epinephrine (E) of
0.12 mcg/kg/min, norepinephrine (NE) 0.05 mcg/kg/min
and milrinone (M) of 0.3mcg/kg/min). During first hour of
transfer, he developed bradycardia, hypotension,
increased left atrial pressure (LAP) of 13 mmHg with
increased chest drainage output. Immediately
cardiopulmonary resuscitation (CPR) was started, IS
increased to 50 (E: 0.3 mcg/kg/min, NE 0.2 mcg/kg/min).
He was transferred back to operating room with active
CPR. After approximately 45 minutes of CPR, the neonate
was placed back on the CPB machine through right
internal jugular and carotid artery cannulation (12 F and
10 F cannula respectively). LV dysfunction due to
unprepared myocardium was thought to be the cause of
this acute de-compensation. It was felt that the best
chance the neonate had was to be left on cardiopulmonary support for at least 48-72 hours to give the LV
some rest and recovery post-surgery. At this time, plan
was made to convert the CPB machine to an
extracorporeal membrane oxygenator (ECMO) circuit and
move the neonate to the CICU. Conventional bypass
machine was transformed into a modified ECMO circuit
after removing arterial filter and addition of a bridge in
arterial-venous line. The paediatric cardiotomy reservoir
was used as the pre-oxygenator bladder, a hollow fiber
oxygenator (MEDOS HILITE 1000, GISH biomedical INC.
California, USA) with a built in heat exchanger (HCU 20)
was used as the membrane oxygenator (MO) (Figure-1
and 2). The air-mixer blender was attached to the MO as a
source of sweep gas. A single roller pump (COBE
Cardiovascular Inc. Colorado, USA) was used. Silicone
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Figure-1: Portion of ECMO circuit showing the cardiotomy reservoir (used as a substitute for bladder), membrane oxygenator with built in heat exchanger and ultrafiltration filter.

Figure-2: Complete ECMO circuit.
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tubes were used for the "race course" portion of the circuit
whilst regular polythene tubing completed the rest of the
circuit. DLP (Medtronic's, Minneapolis, USA) pressure
boxes were used to determine pre and post membrane
pressures. The pre and post-membrane pressures were
trended and monitored for any increase in pre-membrane
pressures (>150mmHg) or difference in the pre/post
membrane pressures (>50mmHg) to determine the
integrity of the MO. Change in post-membrane partial
pressure of oxygen at a constant sweep speed was also
trended every 8 hours as another check for MO integrity.
Another crystalloid primed circuit was kept at the bedside
for emergent replacement if needed. Ultrafiltration was
performed using a filter placed within the circuit. This
venoarterial ECMO set was used to flow at 150 ml/kg to
maintain a mean non-pulsatile blood pressure of 45-55
mmHg. Mean LAP of <8mmHg and a decompressed LV
cavity on echocardiogram was used to determine
effectiveness drainage. Activated clotting time (ACT) was
used to assess the effect of heparin. Due to a cardiac
reservoir instead of a bladder, the pre-reservoir ACT was
kept at 300 IU. Patient ACT (drawn from the patient's
arterial line) was kept at 180-200 IU and heparin was
titrated based on this value. A difference of 100 IU was
usually observed between these 2 values depicting
constant heparin consumption by the cardiotomy
reservoir. Heparin boluses were given in the ECMO venous
line (pre-reservoir) to maintain the above mentioned
values. Packed red blood cells were given to maintain
haematocrit at 35-40%, platelets were maintained at
>100,000, and cryoprecipitate kept the fibrinogen at
>2gm/dl. For the total ECMO duration, a total of 8 units of
packed red blood cells, 1 unit whole blood, 14 units
cryoprecipitate, 8 units of platelets and 6 units of fresh
frozen plasma were transfused. During the course of
ECMO, pulmonary rest ventilation strategy was adopted
with an intermittent ventilator rate of 5 breath/sec,
positive end expiratory pressure of 10mmHg, Tidal
volume of 4ml/kg and inhaled oxygen fraction of 30%.
Inspiratory holds were performed every 8 hours for alveoli
recruitment. One nurse, a perfusionist and physician team
took care of the patient round the clock. Effective left
atrial decompression was observed on echocardiogram
and the need to create an inter-atrial communication for
left atrial decompression was deferred. No circuit or
patient related issues were encountered for the first 60
hours. After which increased chest drainage with
coagulopathy and bleeding started and required several
cryoprecipitate and platelet transfusions. By this time,
pulsatility was observed and the ECMO flow was already
down to idle value of 50ml/kg. He was taken back to the
operation room where he was successfully decannulated
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after 67 hours of being on ECMO. This was the 3rd postoperative day. His head ultrasounds performed
immediately after cannulation and decannulation were
normal. The chest of the patient was closed on the 6th
post-operative day. LVEF improved to 66% at time of chest
closure. He was extubated on the 10th and then
discharged on 28th post-operative day without any
sequel.

Discussion
Use and effectiveness of ECMO in post-operative
congenital heart disease patients is well established in the
developed countries.1,2 The extracorporeal life support
organization (ELSO) in 2006 reported that among those
post-operative congenital heart disease paediatric
patients who were placed on ECMO, 60% were
successfully weaned off and 44% were eventually
discharged from the hospital.8 Improved outcome with
the implication of this life saving modality mandates its
usage in any cardiac intensive care unit. Countries with
middle income economies i.e. India, Egypt, and South
Africa have described ECMO use,7 but to the best of our
knowledge, this is the first report of ECMO use from
Pakistan. We demonstrated that in the absence of a
complete ECMO set up, with some modifications a CPB
machine can be converted and used as an ECMO. To
decrease the chance of circuit thrombosis, the arterial air
filter was removed and a bridge created between the
venous and arterial portion of the circuit. Unavailability of
a bladder and use of the cardiac reservoir as a substitute
required running higher pre-reservoir ACTs and did
eventually pose issues with bleeding at the 60th hour of
ECMO run. Titrating ACTs based on patient's blood sample
rather than from circuit may be a solution to overcome
this issue. Hollow fiber MO may not be designed to work
for long CPB runs. Given the unpredictability of such a MO,
we used pre and post membrane pressures and post
membrane PaO2 as checks for MO integrity. Another
crystalloid primed circuit was kept at the bedside for
emergent replacement if needed.
Though we demonstrate use of ECMO, we do advocate
cautious and appropriate use in a low-income setting like
Pakistan. ECMO is a labour-intensive and expensive
modality with an estimated total hospital cost of $20,000
to $90,000 per patient in developed countries.1 Our
patient survived after ECMO institution of 67 hours with
total length of hospital stay of 25 days. Total cost of ECMO
institution was 98,408,1 Pakistani rupees or $9840
whereas total cost of stay was over 3 million Pakistani
rupees. The personal support required was substantial
with approximately 800 person-hours instituted for the
care of this patient.
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Conclusion
This successful experience of ECMO use from a lowincome country with limited resources and unavailability
of advanced equipment is hopeful and provides an option
in reversible cardiorespiratory compromise refractory to
standard ICU therapy. Such a modality should be used in
highly selective cases where reversibility is anticipated.
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